抗糖尿病DPP4抑制剂通过巨细胞核脉细胞交叉干线减轻椎间盘退化

Chen-Cheng Zhou1, Cheng-Long Xie1, Xiang-Cheng Zhang1

  • 1Key Laboratory of Orthopaedics of Zhejiang Province, Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

PubMed
概括

双基化酶4 (DPP4) 驱动椎间盘退化 (IVDD). 使用西塔利普丁抑制DPP4,通过调节巨细胞核脉细胞相互作用和炎症来减少IVDD的进展.